Pharmacological treatment of monogenic disease.
Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK. liz@gwmail.jr2.ox.oc.uk
D J
DJ
Weatherall
D000755:Anemia, Sickle Cell / Q000188:drug therapy / Q000235:genetics; D000818:Animals; D030342:Genetic Diseases, Inborn / Q000188:drug therapy* / Q000235:genetics*; D005819:Genetic Markers / Q000235:genetics; D006454:Hemoglobins / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D010661:Phenylketonurias / Q000188:drug therapy / Q000235:genetics
D005819:Genetic Markers; D006454:Hemoglobins; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors